Company Overview and News

1
20 Oil Stocks for an Unpredictable Second Half

14h investorplace
Despite their enticing nature, oil stocks are always tricky. Subject to multiple factors, particularly geopolitical pressures, the energy sector is often a hit-or-miss affair. Additionally, with the current Trump administration at the helm over unprecedented issues, this year should be especially unpredictable.

 
ExxonMobil CEO's Solution on Shares: Drill Big, Drill Better

15h rigzone
(Bloomberg) -- Darren Woods is mounting a strong defense of his plan to rescue Exxon Mobil Corp. from its share-price slump with $200 billion of investment over seven years that’s at odds with the belt-tightening undertaken by rivals.

 
ExxonMobil to Slash Gas Flaring 25% by 2020 in Emissions Push

15h rigzone
(Bloomberg) -- Exxon Mobil Corp. plans to reduce the amount of natural gas it burns as waste by a quarter within two years to reduce climate-changing emissions, something long demanded by environmental groups and activist investors.

 
PRESS DIGEST- British Business - May 23

2018-05-22 reuters
May 23 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

 
BP to cut 3 percent of upstream jobs by year-end

2018-05-22 channelnewsasia
British oil giant BP Plc plans to cut 3 percent of jobs in its exploration and production as part of a restructuring of its upstream operations to make the division more efficient and flexible, The Financial Times reported on Tuesday.

 
BP To Cut 3% Of Upstream Jobs By Year-End

2018-05-22 rigzone
May 22 (Reuters) - British oil giant BP Plc said it plans to cut 3 percent of jobs in exploration and production, as part of a restructuring of its global upstream business to make the division more efficient and competitive.

1
BP / BP Plc SD

2018-05-22 sec.gov
Document UNITED STATES

 
BP to cut 3 percent of jobs in upstream business: FT

2018-05-22 reuters
(Reuters) - British oil giant BP Plc plans to cut 3 percent of jobs in its exploration and production as part of a restructuring of its upstream operations to make the division more efficient and flexible, The Financial Times reported on Tuesday.

 
BP to cut 3 percent of jobs in upstream business: FT - Channel NewsAsia

2018-05-22 channelnewsasia
British oil giant BP Plc plans to cut 3 percent of jobs in its exploration and production as part of a restructuring of its upstream operations to make the division more efficient and flexible, The Financial Times reported on Tuesday.

 
BP Sees Legal Jeopardy in Activists' Push for Climate Action

2018-05-21 rigzone
(Bloomberg) -- After paying more than $65 billion in legal costs for the Deepwater Horizon catastrophe, BP Plc is wary of the risk of lawsuits related to climate change.

 
 
Forget About Oil at $80. The Big Rally Is in Forward Prices

2018-05-21 rigzone
(Bloomberg) -- Brent crude oil grabbed all the attention after spot prices hit $80 a barrel last week. And yet, almost unnoticed, a perhaps more important rally has occurred in the obscure world of forward prices, with some investors betting the "lower for longer" price mantra is all but over.

 
Forget about oil at $80. The big rally is in forward prices

2018-05-21 worldoil
NEW YORK and LONDON (Bloomberg) -- Brent crude oil grabbed all the attention after spot prices hit $80/bbl last week. And yet, almost unnoticed, a perhaps more important rally has occurred in the obscure world of forward prices, with some investors betting the "lower for longer" price mantra is all but over.

 
BP Is Said in Talks for Conoco's UK Field Stake in Swap

2018-05-18 rigzone
(Bloomberg) -- BP Plc and ConocoPhillips are in discussions for an asset swap deal that would see the U.K. energy major gain a greater foothold in a key project in the North Sea and the U.S. explorer get Alaskan assets, according to people familiar with the talks.

 
Here's Why You Should Still Hold on to TOTAL (TOT) Stock

2018-05-18 zacks
TOTAL S.A. (TOT - Free Report) stands to benefit from its new upstream startups, initiatives to lower operating expenses, strategic acquisitions and agreements, all of which continue to expand its operation on a global scale.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 055622104